July 10, 2026
Allotera Therapeutics
Allotera Therapeutics expanded its Series C round to $150 million through a combination of equity and venture debt to advance its cancer therapy.
- Round
- Series C
- Amount raised
- $35M
- Lead investor
- —
- Industry
- Biotech, Pharmaceuticals
- Headquarters
- St. Louis, United States
- Employees
- —
- Website
- —
- —
Source: St. Louis Business Journal